Master production and control records lack complete manufacturing and control instructions.
Inspection Record
Charles River Laboratories — FDA 483 Findings
Inspectors Scott T Ballard · Christian LynchThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Records fail to include an individual inventory record of each component and drug product container with sufficient information to allow determination of any associated batch or lot of drug product.
Buildings used in the of a drug product are not maintained in a good state of repair.
Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Fenwal International, Inc.2024-09-18 · US FDASimilar to finding 3 Buildings used in the of a drug product are not maintained in a good state of repair.
- Baxter Healthcare Corporation2025-11-25 · US FDASimilar to finding 4 Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
- Eugia Pharma Specialities Limited2025-11-14 · US FDASimilar to finding 5 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic…
- Aurobindo Pharma Limited Unit 162019-03-01 · US FDASimilar to finding 4 Employees engaged in the manufacture and processing of a drug product lack the training required to perform their assigned functions.
- Eugia Steriles Private Limited2026-06-19 · US FDASimilar to finding 5 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation ofthe aseptic…
A record as of the US FDA document published on 2026-10-30. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.